Stryker Corp (SYK)
328.45
+1.82
(+0.56%)
USD |
NYSE |
May 03, 16:00
328.37
-0.08
(-0.02%)
Pre-Market: 20:00
Stryker Accounts Receivable (Quarterly): 3.473B for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.473B |
December 31, 2023 | 3.765B |
September 30, 2023 | 3.276B |
June 30, 2023 | 3.261B |
March 31, 2023 | 3.215B |
December 31, 2022 | 3.565B |
September 30, 2022 | 3.103B |
June 30, 2022 | 3.145B |
March 31, 2022 | 2.991B |
December 31, 2021 | 3.022B |
September 30, 2021 | 2.817B |
June 30, 2021 | 2.714B |
March 31, 2021 | 2.616B |
December 31, 2020 | 2.701B |
September 30, 2020 | 2.426B |
June 30, 2020 | 2.203B |
March 31, 2020 | 2.646B |
December 31, 2019 | 2.893B |
September 30, 2019 | 2.438B |
June 30, 2019 | 2.408B |
March 31, 2019 | 2.284B |
December 31, 2018 | 2.332B |
September 30, 2018 | 2.076B |
June 30, 2018 | 2.089B |
March 31, 2018 | 2.108B |
Date | Value |
---|---|
December 31, 2017 | 2.198B |
September 30, 2017 | 1.965B |
June 30, 2017 | 1.905B |
March 31, 2017 | 1.875B |
December 31, 2016 | 1.967B |
September 30, 2016 | 1.803B |
June 30, 2016 | 1.758B |
March 31, 2016 | 1.591B |
December 31, 2015 | 1.662B |
September 30, 2015 | 1.496B |
June 30, 2015 | 1.50B |
March 31, 2015 | 1.521B |
December 31, 2014 | 1.572B |
September 30, 2014 | 1.529B |
June 30, 2014 | 1.503B |
March 31, 2014 | 1.43B |
December 31, 2013 | 1.518B |
September 30, 2013 | 1.37B |
June 30, 2013 | 1.413B |
March 31, 2013 | 1.408B |
December 31, 2012 | 1.43B |
September 30, 2012 | 1.356B |
June 30, 2012 | 1.368B |
March 31, 2012 | 1.472B |
December 31, 2011 | 1.417B |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
2.203B
Minimum
Jun 2020
3.765B
Maximum
Dec 2023
2.934B
Average
2.942B
Median
Accounts Receivable (Quarterly) Benchmarks
Boston Scientific Corp | 2.304B |
Haemonetics Corp | 211.61M |
Abbott Laboratories | 6.565B |
Zimmer Biomet Holdings Inc | 1.446B |
ResMed Inc | 779.26M |